PDL BIOPHARMA, INC. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 1, 2010

Attached files

file filename
10-K - FORM 10-K - PDL BIOPHARMA, INC.d10k.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - PDL BIOPHARMA, INC.dex211.htm
EX-32.1 - CERTIFICATION OF PEO AND PFO AS REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) - PDL BIOPHARMA, INC.dex321.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) - PDL BIOPHARMA, INC.dex312.htm
EX-31.1 - CERTIFICATION OF PEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) - PDL BIOPHARMA, INC.dex311.htm
EX-10.29 - OFFER LETTER BETWEEN THE COMPANY AND CHRISTOPHER STONE - PDL BIOPHARMA, INC.dex1029.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

 

  (1) Registration Statement (Form S-3 No. 333-36708) of PDL BioPharma, Inc.,

 

  (2) Registration Statement (Form S-3 No. 333-122760) of PDL BioPharma, Inc.,

 

  (3) Registration Statement (Form S-3 No. 333-123958) of PDL BioPharma, Inc.,

 

  (4) Registration Statement (Form S-3 No. 333-128644) of PDL BioPharma, Inc.,

 

  (5) Registration Statement (Form S-8 No. 333-125906) pertaining to the 2005 Equity Incentive Plan of PDL BioPharma, Inc.,

 

  (6) Registration Statement (Form S-8 No. 333-44762) pertaining to the 1993 Employee Stock Purchase Plan of PDL BioPharma, Inc.,

 

  (7) Registration Statement (Form S-8 No. 333-87957) pertaining to the 1999 Stock Option Plan and 1999 Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,

 

  (8) Registration Statement (Form S-8 No. 33-50116) pertaining to the 2002 Outside Directors Stock Option Plan of PDL BioPharma, Inc.,

 

  (9) Registration Statement (Form S-8 No. 33-50114) pertaining to the 1991 Stock Option Plan of PDL BioPharma, Inc.,

 

  (10) Registration Statement (Form S-8 No. 33-96318) pertaining to the 1991 Stock Option Plan of PDL BioPharma, Inc.,

 

  (11) Registration Statement (Form S-8 No. 333-68314) pertaining to the 1999 Stock Option Plan and 1999 Nonstatutory Stock Option Plan of PDL BioPharma, Inc.,

 

  (12) Registration Statement (Form S-8 No. 333-104170) pertaining to the 1999 Nonstatutory Stock Option Plan and 2002 Outside Directors Stock Option Plan of PDL BioPharma, Inc.,

 

  (13) Registration Statement (Form S-8 No. 333-125906) pertaining to the 2005 Equity Incentive Plan of PDL BioPharma, Inc., and

 

  (14) Registration Statement (Form S-8 No. 333-145262) pertaining to the 2005 Equity Incentive Plan and the 1993 Employee Stock Purchase Plan of PDL BioPharma, Inc.

of our report dated March 1, 2010, with respect to the consolidated financial statements and schedule of PDL BioPharma, Inc., and the effectiveness of internal control over financial reporting of PDL BioPharma, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2009.

/s/ Ernst & Young LLP

Palo Alto, California

March 1, 2010

PDL BIOPHARMA, INC. Reports